Stay updated on Avelumab Entinostat in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab Entinostat in Ovarian Cancer Clinical Trial page.

Latest updates to the Avelumab Entinostat in Ovarian Cancer Clinical Trial page
- Check3 days agoChange DetectedThe site revision label was updated from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check10 days agoChange DetectedThe ClinicalTrials.gov page now displays the study record for a trial of avelumab with or without entinostat in advanced epithelial ovarian cancer, including its design, eligibility criteria, outcome measures, and study documents.SummaryDifference65%

- Check17 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0; the page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedAn NIH-wide notice about the terminology shift from “Artificial Intelligence” to “Super Intelligence” appears above the unchanged 403 error page. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check45 days agoChange DetectedThe footer shows an updated ClinicalTrials.gov site revision, from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check59 days agoChange DetectedThe study record page now displays a 403 Forbidden message, making the study details unavailable to visitors. This reflects a site access issue rather than a content update.SummaryDifference20%

Stay in the know with updates to Avelumab Entinostat in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Entinostat in Ovarian Cancer Clinical Trial page.